| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | 0.038 | 0.8 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |